13F manager/BIIB/

Berkshire Hathaway other Biogen Inc.

Berkshire Hathaway other $157.4K of disclosed value in Biogen Inc..

Signal
Investor Move
Action
Other
Capital
$157.4K disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Filing summary

Period End
Dec 31, 2020
Total Changes
47
New
44
Reduced/Sold
0

Filing changes

TickerCompanyActionCurrent ValuePortfolio Impact
AAPL.MXApple Inc.New$117.7M0.44%
BACBank of America CorporationNew$30.6M0.11%
KOThe Coca-Cola CompanyNew$21.9M0.08%
AXPAmerican Express CompanyNew$18.3M0.07%
KHCThe Kraft Heinz CompanyNew$11.3M0.04%
MCOMoody's CorporationNew$7.2M0.03%
USBU.S. BancorpNew$6.1M0.02%
VZVerizon Communications Inc.Increased$8.6M0.02%
DVADaVita Inc.New$4.2M0.02%
CHTRCharter Communications, Inc.New$3.4M0.01%
BNYBank of New York Mellon CorpNew$3.1M0.01%
GMGeneral Motors CompanyNew$3M0.01%
9.2343E+106VERISIGN INCNew$2.8M0.01%
ABBVAbbVie Inc.New$2.7M0.01%
MRKMerck & Co., Inc.New$2.3M0.01%
V.BAVisa Inc.New$2.2M0.01%
BMYBristol-Myers Squibb CompanyNew$2.1M0.01%
LSXMKUSDLIBERTY MEDIA COR-SIRIUSXM CNew$1.9M0.01%
AMZNAmazon.com, Inc.New$1.7M0.01%
SNOWSnowflake Inc.New$1.7M0.01%

Evidence